AXL and melanoma: Some of the cancers in which AXL is frequently reported to be dysregulated include breast cancer [52, 53], non-small cell lung carcinoma (NSCLC) [54–56], colorectal cancer [57], ovarian cancer [58], pancreatic cancer [59], prostate cancer [60], melanoma [61] and AML [12, 62–64].